Neurobiology of Risk for Bipolar Disorder

Current Treatment Options in Psychiatry

Volumn 3, Issue 4, 2016, Pages 315-329

  Özerdem, Ayşegül ^a   Ceylan, Deniz ^a,b   Can, Güneş ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b Psychiatry Clinic Gümü hane State Hospital   (Turkey)

Author keywords

Bipolar disorder; Brain imaging; Endophenotype; Neurocognition; Oxidative stress; Relatives; Risk

Indexed keywords

EID: 85019639185     PISSN: None     EISSN: 21963061     Source Type: Journal    
DOI: 10.1007/s40501-016-0093-6     Document Type: Review

References (97)

1. Baldessarini RJ, Bolzani L, Cruz N, Jones PB, Lai M, Lepri B, et al. Onset-age of bipolar disorders at six international sites. J Affect Disord. 2010;121(1–2):143–6.
2. Lichtenstein P, Yip BH, Pawitan Y, Cannon TD, Sullivan PF, Hultman CM. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234–9.
3. Kieseppa T, Partonen T, Haukka J, Kaprio J, Lonnqvist J. High concordance of bipolar I disorder in a nationwide sample of twins. Am J Psychiatry. 2004;161:1814–21.
4. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry. 2003;60:497–502.
5. Lapalme M, Hodgins S, LaRoche C. Children of parents with bipolar disorder: a metaanalysis of risk for mental disorders. Can J Psychiatry. 1997;42(6):623–31.
6. Hirschfeld RMA, Lewis L, Vornik LA. Perceptions and impact of bipolar disorder: how far have we really come? Results of the National Depressive and Manic-Depressive Association 2000 survey of individuals with bipolar disorder. J Clin Psychiatry. 2003;64:161–74.
7. Kendler KS, Neale MC. Endophenotype: a conceptual analysis. Mol Psychiatry. 2010;15:789–97.
8. Glahn DC, Bearden CE, Niendam TA, Escamilla MA. The feasibility of neuropsychological endophenotypes in the search for genes associated with bipolar affective disorder. Bipolar Disord. 2004;6(3):171–82.
9. Antila M, Tuulio-Henriksson A, Kieseppa T, Soronen P, Palo OM, Paunio T, et al. Heritability of cognitive functions in families with bipolar disorder. Am J Med Genet. 2007;44:802–8.
10. Glahn DC, Almasy L, Barguil M, Hare E, Peralta JM, Kent Jr JW, et al. Neurocognitive endophenotypes for bipolar disorder identified in multiplex multigenerational families. Arch Gen Psychiatry. 2010;67(2):168–77.
11. Daban C, Mathieu F, Raust A, Cochet B, Scott J, Etain B, et al. Is processing speed a valid cognitive endophenotype for bipolar disorder? J Affect Disord. 2012;139(1):98–101.
12. Arts B, Jabben N, Krabbendam L, van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol Med. 2008;38:771–85.
13. Balanzá-Martinez V, Rubio C, Selva-Vera G, Martinez-Aran A, Sánchez-Moreno J, Salazar-Fraile J, et al. Neurocognitive endophenotypes (Endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci Biobehav Rev. 2008;32:1426–38.
14. Bora E, Yucel M, Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord. 2009;113(1–2):1–20.
15. de la Serna E, Vila M, Sanchez-Gistau V, Moreno D, Romero S, Sugranyes G, et al. Neuropsychological characteristics of child and adolescent offspring of patients with bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2016;65:54–9.
16. Patino LR, Adler CM, Mills NP, Strakowski SM, Fleck DE, Welge JA, et al. Conflict monitoring and adaptation in individuals at familial risk for developing bipolar disorder. Bipolar Disord. 2013;15:264–71.
17. Deveci E, Ozan E, Kirpinar I, Oral M, Daloglu AG, Aydın N, et al. Neurocognitive functioning in young high-risk offspring having a parent with bipolar I disorder. Turk J Med Sci. 2013;43:110–7.
18. McCormack C, Green MJ, Rowland JE, Roberts G, Frankland A, Hadzi-Pavlovic D, et al. Neuropsychological and social cognitive function in young people at genetic risk of bipolar disorder. Psychol Med. 2016;46(4):745–58.
19. Belleau EL, Phillips ML, Birmaher B, Axelson DA, Ladouceur CD. Aberrant executive attention in unaffected youth at familial risk for mood disorders. J Affect Disord. 2013;147(1–3):397–400.
20. Erol A, Kosger F, Putgul G, Ersoy B. Ventral prefrontal executive function impairment as a potential endophenotypic marker for bipolar disorder. Nord J Psychiatry. 2014;68(1):18–23.
21. Kosger F, Essizoglu A, Baltacioglu M, Ulkgun N, Yenilmez C. Executive function in parents of patients with familial versus sporadic bipolar disorder. Compr Psychiatry. 2015;61:36–41.
22. Olvet DM, Burdick KE, Cornblatt BA. Assessing the potential to use neurocognition to predict who is at risk for developing bipolar disorder: a review of the literature. Cogn Neuropsychiatry. 2013;18(12):129–45.
23. Hıdıroglu C, Torres IJ, Er A, Isık G, Yalın N, Yatham LN, et al. Response inhibition and interference control in patients with bipolar I disorder and first-degree relatives. Bipolar Disord. 2015;17:781–94.
24. Doyle AE, Wozniak J, Wilens TE, Henin A, Seidman LJ, Petty C, et al. Neurocognitive impairment in unaffected siblings of youth with bipolar disorder. Psychol Med. 2009;39(8):1253–63.
25. Wessa M, Kollmann B, Linke J, Schönfelder S, Kanske P. Increased impulsivity as a vulnerability marker for bipolar disorder: evidence from self-report and experimental measures in two high-risk populations. J Affect Disord. 2015;178(1):8–24.
26. Kravariti E, Schulze K, Kane F, Kalidindi S, Bramon E, Walshe M, et al. Stroop-test interference in bipolar disorder. Br J Psychiatry. 2009;194(3):285–6.
27. Schulze KK, Walshe M, Stahl D, Hall MH, Kravariti E, Morris R, et al. Executive functioning in familial bipolar I disorder patients and their unaffected relatives. Bipolar Disord. 2011;13:208–16.
28. Ethridge LE, Soilleux M, Nakonezny PA, Reilly JL, Hill SK, Keefe RSE, et al. Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit. Schizophr Res. 2014;159:491–8.
29. Sanchesa M, Scott-Gurnella K, Patela A, Caetanob SC, Zunta-Soaresa GB, et al. Impulsivity in children and adolescents with mood disorders and unaffected offspring of bipolar parents. Compr Psychiatry. 2014;55:1337–41.
30. Fortgang RG, Hultman CM, van Erp TG, Cannon D. Multidimensional assessment of impulsivity in schizophrenia, bipolar disorder, and major depressive disorder: testing for shared endophenotypes. Psychol Med. 2016;46(7):1497–507.
31. Lombardo LE, Bearden CE, Barrett J, Brumbaugh MS, Pittman B, Frangou S, et al. Trait impulsivity as an endophenotype for bipolar I disorder. Bipolar Disord. 2012;14:565–70.
32. Ng TH, Stange JP, Black CL, Titone MK, Weiss RB, Abramson LY, et al. Impulsivity predicts the onset of DSM-IV-TR or RDC hypomanic and manic episodes in adolescents and young adults with high or moderate reward sensitivity. J Affect Disord. 2016;198:88–95.
33. Hıdıroğlu C, Demirci Esen O, Tunca Z, Gürz Yalçın N, Lombardo L. Can risk taking be an endophenotype for bipolar disorder? A study on patients with bipolar disorder type I and their first-degree relatives. J Int Neuropsychol Soc. 2013;19:474–82.
34. Brotman MA, Guyer AE, Lawson ES, Horsey SE, Rich BA, Dickstein DP, et al. Facial emotion labeling deficits in children and adolescents at risk for bipolar disorder. Am J Psychiatry. 2008;165:385–9.
35. Brotman MA, Skup M, Rich BA, Blair KS, Pine DS, Blair JR, et al. Risk for bipolar disorder is associated with face processing deficits across emotions. J Am Acad Child Adolesc Psychiatry. 2008;47(12):1455–61.
36. Vierck E, Porter RJ, Joyce PR. Facial recognition deficits as a potential endophenotype in bipolar disorder. Psychiatry Res. 2015;230:102–7.
37. Seidel EM, Habel U, Finkelmeyer A, Hasmann A, Dobmeier M, Derntl B. Risk or resilience? Empathic abilities in patients with bipolar disorders and their first-degree relatives. Psychiatry Res. 2012;46:382–8.
38. Hanford LC, Sassi RB, Hall GB. Accuracy of emotion labeling in children of parents diagnosed with bipolar disorder. J Affect Disord. 2016;194:226–33.
39. Brand JG, Goldberg TE, Gunawardane N, Gopin CB, Powers RL, Malhotra AK, et al. Emotional bias in unaffected siblings of patients with bipolar I disorder. J Affect Disord. 2012;136:1053–8.
40. Reynolds MT, Van Rheenen TE, Rossell SL. Theory of mind in first degree relatives of individuals with bipolar disorder. Psychiatry Res. 2014;219:400–2.
41. Wang YG, Roberts DL, Liang Y, Shi JF, Wang K. Theory of mind understanding and theory-of-mind use in unaffected first-degree relatives of schizophrenia and bipolar disorder. Psychiatry Res. 2015;230(2):735–7.
42. Martino DJ, Samamé C, Ibañez A, Strejilevich SA. Neurocognitive functioning in the premorbid stage and in the first episode of bipolar disorder: a systematic review. Psychiatry Res. 2015;226:23–30. This article compiles data on the premorbid stage of individuals, who later on develop BD and on first episode patients and showing that deficits in specific cognitive domains precede the onset of illness.
43. Trotta A, Murray RM, MacCabe JH. Do premorbid and post-onset cognitive functioning differ between schizophrenia and bipolar disorder? A systematic review and meta-analysis. Psychol Med. 2015;45(2):381–94.
44. Zalla T, Joyce C, Szöke A, Schürhoff F, Pillon B, Komano O, et al. Executive dysfunctions as potential markers of familial vulnerability to bipolar disorder and schizophrenia. Psychiatry Res. 2004;121(3):207–17.
45. Kim D, Kim JW, Koo TH, Yun HR, Won SH. Shared and distinct neurocognitive endophenotypes of schizophrenia and psychotic bipolar disorder. Clin Psychopharmacol Neurosci. 2015;13(1):94–102.
46. Kumar CT, Christodoulou T, Vyas NS, Kyriakopoulos M, Corrigall R, Reichenberg A, et al. Deficits in visual sustained attention differentiate genetic liability and disease expression for schizophrenia from bipolar disorder. Schizophr Res. 2010;124:152–60.
47. Rybakowski JK, Borkowska A, Skibinska M, Szczepankiewicz A, Kapelski P, Leszczynska-Rodziewicz A, et al. Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin Neurosci. 2006;60(1):70–6.
48. Fernandes CPD, Christoforou A, Giddaluru S, Ersland KM, Djurovic S, et al. A genetic deconstruction of neurocognitive traits in schizophrenia and bipolar disorder. PLoS One. 2013;8(12):e81052.
49. Besnier N, Richard F, Zendjijian X, Kaladjian A, Mazzola-Pomietto P, Adida M, et al. Stroop and emotional Stroop interference in unaffected relatives of patients with schizophrenic and bipolar disorders: distinct markers of vulnerability? World J Biol Psychiatry. 2009;10(4):809–18.
50. Szöke A, Schürhoff F, Golmard JL, Alter C, Roy I, Méary A, et al. Familial resemblance for executive functions in families of schizophrenic and bipolar patients. Psychiatry Res. 2006;144(2–3):131–8.
51. Ivleva EI, Morris DW, Osuji J, Moates AF, Carmody TJ, Thaker GK, et al. Cognitive endophenotypes of psychosis within dimension and diagnosis. Psychiatry Res. 2012;196(1):38–44.
52. Georgiades A, Rijsdijk F, Kane F, Rebollo-Mesa I, Kalidindi S, Schulze KK, et al. New insights into the endophenotypic status of cognition in bipolar disorder: genetic modelling study of twins and siblings. Br J Psychiatry. 2016;208(6):539–47.
53. Bora E. Developmental trajectory of cognitive impairment in bipolar disorder: comparison with schizophrenia. Eur Neuropsychopharmacol. 2015;25(2):158–68. This article is an extensive review on cognitive data, obtained at the premorbid stage, in first episode and from FDR and discussing delicately the diversity and origins of premorbid cognitive impairment in BD with a particular focus on the overlapping genetic infrastructure with SCH.
54. Antila M, Kieseppä T, Partonen T, Lönnqvist J, Tuulio-Henriksson A. The effect of processing speed on cognitive functioning in patients with familial bipolar I disorder and their unaffected relatives. Psychopathology. 2011;44:40–5.
55. Fusar-Poli P, Howes O, Bechdolf A, Borgwardt S. Mapping vulnerability to bipolar disorder: a systematic review and meta-analysis of neuroimaging studies. J Psychiatry Neurosci. 2012;37(3):170.
56. Ising M, Lauer CJ, Holsboer F, Modell S. The Munich vulnerability study on affective disorders: premorbid neuroendocrine profile of affected high-risk probands. J Psychiatr Res. 2005;39(1):21–8.
57. Nery FG, Monkul ES, Lafer B. Gray matter abnormalities as brain structural vulnerability factors for bipolar disorder: a review of neuroimaging studies of individuals at high genetic risk for bipolar disorder. Aust N Z J Psychiatry. 2013;47(12):1124–35.
58. Eker C, Simsek F, Yılmazer EE, Kitis O, Cinar C, Eker OD, et al. Brain regions associated with risk and resistance for bipolar I disorder: a voxel-based MRI study of patients with bipolar disorder and their healthy siblings. Bipolar Disord. 2014;16(3):249–61.
59. Sarıçiçek A, Yalın N, Hıdıroğlu C, Çavuşoğlu B, Taş C, Ceylan D, et al. Neuroanatomical correlates of genetic risk for bipolar disorder: a voxel-based morphometry study in bipolar type I patients and healthy first degree relatives. J Affect Disord. 2015;186:110–8.
60. Sandoval H, Soares JC, Mwangi B, Asonye S, Alvarado LA, Zavala J, et al. Confirmation of MRI anatomical measurements as endophenotypic markers for bipolar disorder in a new sample from the NIMH Genetics of Bipolar Disorder in Latino Populations study. Psychiatry Res. 2016;247:34–41.
61. Nery FG, Gigante AD, Amaral JA, Fernandes FB, Berutti M, Almeida KM, et al. Gray matter volumes in patients with bipolar disorder and their first-degree relatives. Psychiatry Res. 2015;234(2):188–93.
62. Fears SC, Schür R, Sjouwerman R, Service SK, Araya C, Araya X, et al. Brain structure-function associations in multi-generational families genetically enriched for bipolar disorder. Brain. 2015;138:2087–102.
63. van Erp TG, Thompson PM, Kieseppä T, Bearden CE, Marino AC, Hoftman GD, et al. Hippocampal morphology in lithium and non-lithium-treated bipolar I disorder patients, non-bipolar co-twins, and control twins. Hum Brain Mapp. 2012;33(3):501–10.
64. Ladouceur CD, Almeida JR, Birmaher B, Axelson DA, Nau S, Kalas C, et al. Subcortical gray matter volume abnormalities in healthy bipolar offspring: potential neuroanatomical risk marker for bipolar disorder? J Am Acad Child Adolesc Psychiatry. 2008;47(5):532–9.
65. Walterfang M, Wood AG, Barton S, Velakoulis D, Chen J, Reutens DC, et al. Corpus callosum size and shape alterations in individuals with bipolar disorder and their first-degree relatives. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33(6):1050–7.
66. Boccardi M, Almici M, Bresciani L, Caroli A, Bonetti M, Monchieri S, et al. Clinical and medial temporal features in a family with mood disorders. Neurosci Lett. 2010;468(2):93–7.
67. Hajek T, Gunde E, Bernier D, Slaney C, Propper L, Macqueen G, et al. Pituitary volumes in relatives of bipolar patients: high-risk study. Eur Arch Psychiatry Clin Neurosci. 2008;258(6):357–62.
68. Arat HE, Chouinard VA, Cohen BM, Lewandowski KE, Öngür D. Diffusion tensor imaging in first degree relatives of schizophrenia and bipolar disorder patients. Schizophr Res. 2015;161(2–3):329–39. This article compiled data on white matter abnormalities in first-degree relatives of bipolar disorder patients, compared white matter abnormalities of first degree relatives of SCH-P and BD-P.
69. Sarıçiçek A, Zorlu N, Yalın N, Hıdıroğlu C, Çavuşoğlu B, Ceylan D, et al. Abnormal white matter integrity as a structural endophenotype for bipolar disorder. Psychol Med. 2016;46(7):1547–58.
70. Chaddock CA, Barker GJ, Marshall N, Schulze K, Hall MH, Fern A, et al. White matter microstructural impairments and genetic liability to familial bipolar I disorder. Br J Psychiatry. 2009;194(6):527–34.
71. Emsell L, Chaddock C, Forde N, Van Hecke W, Barker GJ, Leemans A, et al. White matter microstructural abnormalities in families multiply affected with bipolar I disorder: a diffusion tensor tractography study. Psychol Med. 2014;44(10):2139–50.
72. Paillère Martinot ML, Lemaitre H, Artiges E, Miranda R, Goodman R, Penttilä J, et al. White-matter microstructure and gray-matter volumes in adolescents with subthreshold bipolar symptoms. Mol Psychiatry. 2014;19(4):462–70.
73. van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V, et al. Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry. 2009;66(2):142–51.
74. Sprooten E, Brumbaugh MS, Knowles EE, McKay DR, Lewis J, Barrett J, et al. Reduced white matter integrity in sibling pairs discordant for bipolar disorder. Am J Psychiatry. 2013;170(11):1317–25.
75. Piguet C, Fodoulian L, Aubry JM, Vuilleumier P, Houenou J. Bipolar disorder: functional neuroimaging markers in relatives. Neurosci Biobehav Rev. 2015;57:284–96. This article summarized all fMRI studies with FDR of BD-P.
76. Solé-Padullés C, Castro-Fornieles J, de la Serna E, Romero S, Calvo A, Sánchez-Gistau V, et al. Altered cortico-striatal connectivity in offspring of schizophrenia patients relative to offspring of bipolar patients and controls. PLoS One. 2016;11(2):e0148045.
77. Sepede G, De Berardis D, Campanella D, Perrucci MG, Ferretti A, Salerno RM, et al. Neural correlates of negative emotion processing in bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;201660:1–10.
78. Dima D, Roberts RE, Frangou S. Connectomic markers of disease expression, genetic risk and resilience in bipolar disorder. Transl Psychiatry. 2016;6(1). e706.
79. Whalley HC, Sussmann JE, Johnstone M, Romaniuk L, Redpath H, Chakirova G, et al. Effects of a mis-sense DISC1 variant on brain activation in two cohorts at high risk of bipolar disorder or schizophrenia. Am J Med Genet B Neuropsychiatr Genet. 2012;159(3):343–53.
80. Mourão-Miranda J, Oliveira L, Ladouceur CD, Marquand A, Brammer M, Birmaher B, et al. Pattern recognition and functional neuroimaging help to discriminate healthy adolescents at risk for mood disorders from low risk adolescents. PLoS One. 2012;7(2):e29482.
81. Heissler J, Kanske P, Schönfelder S, Wessa M. Inefficiency of emotion regulation as vulnerability marker for bipolar disorder: evidence from healthy individuals with hypomanic personality. J Affect Disord. 2014;152:83–90.
82. Deveney CM, Connolly ME, Jenkins SE, Kim P, Fromm SJ, Brotman MA. Striatal dysfunction during failed motor inhibition in children at risk for bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2012;38(2):127–33.
83. Kanske P, Schönfelder S, Forneck J, Wessa M. Impaired regulation of emotion: neural correlates of reappraisal and distraction in bipolar disorder and unaffected relatives. Transl Psychiatry. 2015;5(1):497.
84. Breakspear M, Roberts G, Green MJ, Nguyen VT, Frankland A, Levy F, et al. Network dysfunction of emotional and cognitive processes in those at genetic risk of bipolar disorder. Brain. 2015;138(Pt 11):3427–39.
85. McIntosh AM, Hall J, Lymer GKS, Sussmann JE, Lawrie SM. Genetic risk for white matter abnormalities in bipolar disorder. Internat Rev Psychiatry. 2009;21(4):387–93.
86. Whalley HC, Sprooten E, Hackett S, Hall L, Blackwood DH, Glahn DC, et al. Polygenic risk and white matter integrity in individuals at high risk of mood disorder. Biol Psychiatry. 2013;74(4):280–6.
87. Grande I, Magalhães PV, Chendo I, Stertz L, Panizutti B, Colpo GD, et al. Staging bipolar disorder: clinical, biochemical, and functional correlates. Acta Psychiatr Scand. 2014;129(6):437–44.
88. Duffy A, Horrocks J, Doucette S, Keown-Stoneman C, Grof P, Andreazza A, et al. Immunological and neurotrophic markers of risk status and illness development in high-risk youth: understanding the neurobiological underpinnings of bipolar disorder. Int J Bipolar Disord. 2014;2(1):29.
89. Mesman E, Hillegers MH, Ambree O, Arolt V, Nolen WA, Drexhage HA. Monocyte activation, brain-derived neurotrophic factor (BDNF), and S100B in bipolar offspring: a follow-up study from adolescence into adulthood. Bipolar Disord. 2015;17(1):39–49.
90. Scola G, McNamara RK, Croarkin PE, Leffler JM, Cullen KR, Geske JR, et al. Lipid peroxidation biomarkers in adolescents with or at high-risk for bipolar disorder. J Affect Disord. 2016;192:176–83.
91. Vasconcelos-Moreno MP, Kunz M, Ferrari P, Passos IC, Bücker J, et al. BDNF levels in first-degree relatives of patients with bipolar disorder: preliminary data. Bipolar Disord. 2012;14:107.
92. Ceylan D, Ozerdem A, GurzYalcin SN, Hidiroğlu C, Aslan YC, Bağcı B, et al. Can serum BDNF levels be identified as a candidate endophenotype in bipolar disorder? Bipolar Disord. 2012;14:66.
93. Nery FG, Gigante AD, Amaral JA, Fernandes FB, Berutti M, Almeida KM, et al. Serum BDNF levels in unaffected first-degree relatives of patients with bipolar disorder. Rev Bras Psiquiatr. 2016;38(3):197–200.
94. Park MH, Chang KD, Hallmayer J, Howe ME, Kim E, Hong SC, et al. Preliminary study of anxiety symptoms, family dysfunction, and the brain-derived neurotrophic factor (BDNF) Val66Met genotype in offspring of parents with bipolar disorder. J Psychiatr Res. 2015;61:81–8.
95. Ferensztajn E, Skibinska M, Kaczmarek M, Losy J, Rybakowski JK. Neurobiology and temperament in the offspring of excellent lithium responders. World J Biol Psychiatry. 2015;16(4):272–7.
96. Huzayyin AA, Andreazza AC, Turecki G, Cruceanu C, Rouleau GA, Alda M, et al. Decreased global methylation in patients with bipolar disorder who respond to lithium. Int J Neuropsychopharmacol. 2014;17(4):561–9.
97. Yatham LN, Torres IJ, Malhi GS, Frangou S, Glahn DC, Bearden CE, et al. The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition (ISBD-BANC). Bipolar Disord. 2010;12(4):351–63.